The National Institutes of Health (NIH) has announced a new funding opportunity with the number RFA-DA-25-031, focusing on the “Adolescent Overdose Prevention and SUD (Substance Use Disorder) Treatment Initiative.” This grant, classified under discretionary funding, falls into the categories of education and health, specifically targeting drug abuse and addiction research programs. It encourages preliminary research and pilot projects in preparation for large-scale trials aimed at enhancing overdose prevention and SUD treatment for adolescents.
The primary goal of this funding opportunity is to develop interventions that effectively, non-stigmatizingly, and sustainably prevent overdoses and treat SUD in young people. These initiatives may explore areas such as changes in risk behaviors associated with overdose, the use of Naloxone, harm reduction, recovery, treatment retention, effectiveness, quality of care, patient-centered outcomes, and implementation factors. The program is open to a wide range of applicants, including for-profit organizations, Native American tribal governments, private and public educational institutions, government entities, and various non-profit organizations. The application closing date is set for March 13, 2024, and the program aims to develop practical, cost-effective, and scalable solutions for addressing these critical health issues in adolescents.
Opportunity ID: 351038
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-25-031 |
| Funding Opportunity Title: | Adolescent Overdose Prevention and SUD Treatment Initiative (R34 – Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | |
| Expected Number of Awards: | |
| CFDA Number(s): | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 17, 2023 |
| Last Updated Date: | Nov 17, 2023 |
| Original Closing Date for Applications: | Mar 13, 2024 |
| Current Closing Date for Applications: | Mar 13, 2024 |
| Archive Date: | Apr 18, 2024 |
| Estimated Total Program Funding: | |
| Award Ceiling: | $ |
| Award Floor: | $ |
Eligibility
| Eligible Applicants: | For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Private institutions of higher education Independent school districts City or township governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public and State controlled institutions of higher education County governments Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Notice of Funding Opportunity (NOFO) encourages pilot work and preliminary research to support preparation for large-scale, rigorous trials that will guide the expansion of effective, non-stigmatizing overdose prevention, SUD treatment and recovery services for adolescents. These studies could include examining changes in risk behaviors associated with overdose (e.g., using alone, carrying/using Naloxone). Outcomes of interest include but are not limited to harm reduction, recovery, treatment retention and effectiveness, quality of care, patient-centered outcomes, and implementation factors. The goal of this NOFO is to develop interventions that address effective, non-stigmatizing overdose prevention, SUD treatment and recovery services for youth that are effective, practical, cost-effective, scalable, and sustainable. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-031.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact: NIH Grants Information
grantsinfo@nih.gov |